Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Harbor BioMed
Harbor BioMed
Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work
Endpoints
Mon, 08/24/20 - 10:43 am
Vir Biotechnology
Harbor BioMed
cancer
infectious diseases
After Kaletra setback, AbbVie joins forces with biotech, academia for experimental COVID-19 hopeful
Fierce Biotech
Fri, 06/5/20 - 10:37 am
AbbVie
Kaletra
COVID-9
antibodies
Harbor BioMed
47D11
Erasmus Medical Center
Utrecht University
Harbour BioMed nets $75M in Series B+ as first global trial gets underway
Endpoints
Thu, 03/12/20 - 10:50 am
Harbor BioMed
Shanghai
Harbour BioMed gets FDA nod to begin clinical trial for HBM4003 in cancer
Pharmaceutical Business Review
Mon, 03/2/20 - 09:39 am
Harbor BioMed
FDA
HBM4003
clinical trials
solid tumors
cancer